Revelation Biosciences, Inc.

Revelation Biosciences, Inc.verified

REVB

Price:

$0.9963

Market Cap:

$3.89M

Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute kidney injury, and GEM-CKD, intended for the prevention and treatment of chronic kidney disease. Established in 2019, this San Diego, California-based enterprise was formerly known as Petra Acquisition, Inc., before officially adopting the name Revelation Biosciences, Inc. in January 2022.

Industry

Biotechnology

IPO Date

2020-11-17

Stock Exchange

NASDAQ

Ticker

REVB

The Enterprise Value as of June 2026 (TTM) for Revelation Biosciences, Inc. (REVB) is -9460412.00

According to Revelation Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -9460412.00. This represents a change of 188.68% compared to the average of -3277085.14 of the last 4 quarters.

Revelation Biosciences, Inc. (REVB) Historical Enterprise Value (quarterly & annually)

How has REVB Enterprise Value performed in the past?

The mean historical Enterprise Value of Revelation Biosciences, Inc. over the last ten years is 134.54M. The current -9460412.00 Enterprise Value has changed -803.15% with respect to the historical average. Over the past ten years (40 quarters), REVB's Enterprise Value was at its highest in in the December 2021 quarter at 401.50M. The Enterprise Value was at its lowest in in the March 2026 quarter at -9505107.00.

Quarterly (TTM)
Annual

Average

134.54M

Median

37.79M

Minimum

-7966987.00

Maximum

401.49M

Revelation Biosciences, Inc. (REVB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Revelation Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 241.94%

Maximum Annual Enterprise Value = 401.49M

Minimum Annual Increase = -191.75%

Minimum Annual Enterprise Value = -7966987.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-7966987.00-191.75%
20248.68M-70.29%
202329.22M-22.66%
202237.79M-90.59%
2021401.49M241.94%
2020117.42M-66.94%

Revelation Biosciences, Inc. (REVB) Average Enterprise Value

How has REVB Enterprise Value performed in the past?

The current Enterprise Value of Revelation Biosciences, Inc. (REVB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

9.98M

5-year avg

93.84M

10-year avg

134.54M

Revelation Biosciences, Inc. (REVB) Enterprise Value vs. Peers

How is REVB’s Enterprise Value compared to its peers?

Revelation Biosciences, Inc.’s Enterprise Value is less than SciSparc Ltd. (-3730477.00), less than Onconetix, Inc. (-3085440.00), less than Indaptus Therapeutics, Inc. (4.77M), less than GT Biopharma, Inc. (-4175034.00), less than Salarius Pharmaceuticals, Inc. (-4623480.00), less than NKGen Biotech, Inc. Common Stock (46.02M), less than Avenue Therapeutics, Inc. (-1362611.00), less than Psyence Biomedical Ltd. (-6071833.00), less than Azitra, Inc. (-7333404.00), less than Silexion Therapeutics Ltd. (-665546.00),

CompanyEnterprise ValueMarket cap
-3730477.00$494.52K
-3085440.00$340.71K
4.77M$6.27M
-4175034.00$4.75M
-4623480.00$4.92M
46.02M$7.84M
-1362611.00$1.05M
-6071833.00$63.33K
-7333404.00$2.27M
-665546.00$1.31M

Build a custom stock screener for Revelation Biosciences, Inc. (REVB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revelation Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revelation Biosciences, Inc. (REVB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revelation Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Revelation Biosciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Revelation Biosciences, Inc. (REVB)?

What is the 3-year average Enterprise Value for Revelation Biosciences, Inc. (REVB)?

What is the 5-year average Enterprise Value for Revelation Biosciences, Inc. (REVB)?

How does the current Enterprise Value for Revelation Biosciences, Inc. (REVB) compare to its historical average?